Skip to Content

'
Richard De La Garza II, Ph.D.

Present Title & Affiliation

Primary Appointment

Associate Professor and Director of Research, Department of Psychiatry, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1996 University of Texas Medical Branch, Galveston, TX, PHD, Neuroscience
1989 University of North Texas, Denton, TX, MS, Biology
1985 Texas A&M University-Commerce, Commerce, TX, BS, Biology

Postgraduate Training

1999-2000 Post-Doctoral Fellow, Neuroscience, Yale University School of Medicine, New Haven, CT
1996-1999 Post-Doctoral Fellow, Neuroscience, Harvard Medical School, Boston, MA

Selected Publications

Peer-Reviewed Original Research Articles

1. De La Garza R, Zorick T, London ED, Newton TF. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend 106(2-3):173-80, 1/15/2010. e-Pub 9/24/2009. PMCID: PMC2815156.
2. De La Garza R, Ashbrook LH, Evans SE, Jacobsen CA, Kalechstein AD, Newton TF. Influence of verbal recall of a recent stress experience on anxiety and desire for cocaine in non-treatment seeking, cocaine-addicted volunteers. Am J Addict 18(18):481-87, Nov-Dec, 11/2009. PMCID: PMC3341928.
3. De La Garza R, Zorick T, Heinzerling KG, Nusinowitz S, London ED, Shoptaw S, Moody DE, Newton TF. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacol Biochem Behav 94(1):186-93, 11/2009. e-Pub 8/19/2009. PMCID: PMC2775447.
4. Newton TF, De La Garza R, Kalechstein AD, Tziortzis D, Jacobsen CA. Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse. Am J Addict 18(18):294-300, Jul-Aug, 7/2009. PMCID: PMC3341929.
5. Culbertson C, De La Garza R, Costello M, Newton TF. Unrestricted access to methamphetamine or cocaine in the past is associated with increased current use. Int J Neuropsychopharmacol 12(11):729-41, 6/2009. e-Pub 2/16/2009. PMCID: PMC2735335.
6. De La Garza II R, Shoptaw S, Newton TF. Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Neuropsychopharmacol(12):677-85, 2009.
7. Newton TF, Reid MS, De La Garza R, Mahoney JJ, Abad A, Condos R, Palamar J, Halkitis PN, Mojisak J, Anderson A, Li SH, Elkashef A. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol 11(11):1037-45, 12/2008. e-Pub 7/29/2008. PMCID: PMC2782728.
8. De La Garza R, Mahoney JJ, Culbertson C, Shoptaw S, Newton TF. The Acetylcholinesterase Inhibitor Rivastigmine Does Not Alter Total Choices for Methamphetamine, but May Reduce Positive Subjective Effects, in a Laboratory Model of Intravenous Self-Administration in Human Volunteers. Pharmacol Biochem Behav 89(89):200-208, 4/2008. e-Pub 1/22/2008. PMID: 18207225.

Last updated: 6/2/2014